Fertility Testing Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Global Fertility Testing Devices Market report has been segmented by Product Type (Ovulation Prediction Kits, Fertility Monitors, and Male Fertility Products), Mode of Purchase (OTC-based and Prescription-based), Application (Female Fertility Testing and Male Fertility Testing), End User (Home Care Settings and Hospitals/Fertility Clinics), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Market Snapshot

Fertility Testing Devices Market Overview
Study Period: 2018-2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 6.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The global fertility testing devices market was estimated at USD 450 million in 2020, and is expected to reach USD 645 million by 2026, witnessing a CAGR of 6.3% over the forecast period.

The contagious coronavirus has had an economic impact and implication on most of the sectors. Human reproduction societies have issued guidelines for practice during the COVID-19 pandemic that include implementation of mitigation practices and infection control protocols in infertility care units. However, the sales of fertility test kits and devices have increased as the birth rate has increased during the lockdown period.

Declining fertility rates are a rising concern, globally. Declining fertility rates, owing to the increasing age for first-time pregnancy and high prevalence of PCOS (polycystic ovary syndrome) among women, are expected to support the growth of the market. In 2017, The United States experienced a record low for a second straight year, extending a deep decline that began in 2008, with the "Great Recession". However, fertility rates among the elderly population have been on a rise over the past few years, owing to increasing awareness about fertility testing.

In Europe, the average fertility rate is 1.6. The lowest fertility rates were recorded in the southern European countries of Italy, Spain, and Portugal, where they range between 1.34 and 1.36, according to Eurostat, 2018.

Fertility rates in China are also decreasing. In China, low fertility rate is a more serious problem than the aging population. According to the National Bureau of Statistics of China, 17.23 million newborns were added to China's population last year, down by 630,000 year-on-year, and the birth rate dropped from 1.295% in 2016 to 1.243% in 2017. Hence, the decreasing fertility rates and increasing lifestyle disorders among the global population are expected to drive the market during the forecast period.

There are several computerized fertility monitors that are used to detect urinary LH and estrone‐3‐glucoronide, which, if present in urine, indicates ovulation. For example, Clearblue DIGITAL Ovulation Test with Dual Hormone Indicator, of SPD Swiss Precision Diagnostics GmbH, detects estrogen as well as LH, and claims that the product can identify four or more fertile days with an accuracy rate of over 99%; however, these digital kits are not affordable in many countries due to financial barriers.

Therefore, increasing technological advancements in test kits and a surge in the launch of such kits are expected to boost the market’s growth.

Scope of the Report

Fertility testing is undertaken by both men and women, for the assessment of their fertility and various conditions associated with it. Both men and women experience fertility problems at equal rates, but women are considered to be more concerned about fertility testing. The market is segmented by product type (ovulation prediction kits, fertility monitors (urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors), and male fertility products), mode of purchase (OTC-based, prescription-based), application (female fertility testing, and male fertility testing), end-user (home care settings, and hospitals/fertility clinics), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Ovulation Prediction Kits
Fertility Monitors
Urine-based Ovulation Kits
Saliva-based Ovulation Kits
Other Fertility Monitors
Male Fertility Testing Products
By Mode of Purchase
OTC-based
Prescription-based
By Application
Female Fertility Testing
Male Fertility Testing
By End User
Home Care Settings
Hospitals/Fertility Clinics
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Ovulation Prediction Kits are expected to Witness Healthy Growth over the Forecast Period

The pandemic has had mixed effects on the ovulation kit segment. On one hand, due to the luxury of time offered by the lockdowns, many couples planned for a conception during the pandemic. On the other hand, many organizations estimate that the economic crisis during COVID-19, as well as the resulting unemployment, a surge in domestic violence, and restricted access to healthcare during the antenatal period will affect birth rates, resulting in fewer million babies.

Organizations that deal with reproductive health are recommending, out of caution and concern for the lack of data (regarding the relationship between pregnancy and COVID-19), that couples planning pregnancies should hold off for the time being. The European Society of Human Reproduction and Embryology states that all fertility patients considering or planning treatment, even if they do not meet the diagnostic criteria for COVID-19 infection, should avoid becoming pregnant at this time.

OPKs or ovulation prediction kits are used to detect the exact day of ovulation for a woman who is planning for a conception. There are many kinds of ovulation prediction kits in the market. Most of the kits work by measuring the luteinizing hormone (LH) in the urine. LH levels rise 24-36 hours before ovulation. The high level of LH indicates that the release of the egg (ovulation) usually occurs 12-24 hours after the test turns positive.

According to the Centers for Disease Control, one in eight couples has trouble conceiving or sustaining a pregnancy, due to age, health issues, or other factors. This indicates that there is a need in the market for cost-efficient and accurate ovulation monitors. As OPK provides cost-effective fertility testing, its demand is increasing.

Fertility Testing Devices Market Latest Trends

To understand key trends, Download Sample Report

United States holds the Significant Revenue Share in the North America Region

In June 2021, the Brookings Institution estimated that in the United States, public health crisis and associated recession will result in 300,000 to 500,000 fewer births in 2021. According to the Guttmacher Institute survey, 2020, 34% of American women have either delayed their plans to have a child or reduced the number of children they expect to have because of the pandemic.

In 2018, the United States experienced a record low fertility rate. The fertility rate in the United States in 2018 was 1.776 births per woman, a 1.11% decline from 2017 (1.796). The number of births in the country dropped by 2% between 2016 and 2017, to 60.2 births per 1,000 women aged 15-44 years, continuing a general downward trend that started with the Great Recession of 2008. This marks the lowest that the fertility rate of the country has been in 30 years. According to the National Center for Health Statistics (2017), birthrates declined to record lows among all groups under the age of 30. Among women aged 20-24 years, the decline was 4%, whereas for women aged 25-29 years, the rate fell to 2%.

According to CDC, in 2019, about 6% of married women aged 15-44 years in the United States were unable to conceive after one year of trying. Moreover, about 12% of women aged 15-44 years in the United States have difficulty conceiving or sustaining a pregnancy.

Hence, the decreasing fertility rates and rising awareness about fertility testing are driving the fertility testing device market in the country.

Fertility Testing Devices Market Share By Region

To understand geography trends, Download Sample Report

Competitive Landscape

The market studied is moderately competitive and there are several local as well as international companies present in the market. Several companies are focusing on the new product launches to sustain their competitiveness and it has been observed that few new companies are entering the market studied, which is increasing the competition.

Recent Developments

  • In June 2020, Modern Fertility launched pregnancy and ovulation tests, along with a mobile application to centralize all fertility-related data
  • In March 2020, Proov got FDA clearance for its at-home ovulation testing kit.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Decreasing Fertility Rates

      2. 4.2.2 Rising Awareness about Fertility Testing Devices

      3. 4.2.3 Launch of Advanced, Easy-to-use Fertility Monitors With High Accuracy

    3. 4.3 Market Restraints

      1. 4.3.1 High Price of Ovulation Monitors

      2. 4.3.2 Lack of Predictive Accuracy to Confirm Ovulation

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Ovulation Prediction Kits

      2. 5.1.2 Fertility Monitors

        1. 5.1.2.1 Urine-based Ovulation Kits

        2. 5.1.2.2 Saliva-based Ovulation Kits

        3. 5.1.2.3 Other Fertility Monitors

      3. 5.1.3 Male Fertility Testing Products

    2. 5.2 By Mode of Purchase

      1. 5.2.1 OTC-based

      2. 5.2.2 Prescription-based

    3. 5.3 By Application

      1. 5.3.1 Female Fertility Testing

      2. 5.3.2 Male Fertility Testing

    4. 5.4 By End User

      1. 5.4.1 Home Care Settings

      2. 5.4.2 Hospitals/Fertility Clinics

    5. 5.5 Geography

      1. 5.5.1 North America

        1. 5.5.1.1 United States

        2. 5.5.1.2 Canada

        3. 5.5.1.3 Mexico

      2. 5.5.2 Europe

        1. 5.5.2.1 Germany

        2. 5.5.2.2 United Kingdom

        3. 5.5.2.3 France

        4. 5.5.2.4 Italy

        5. 5.5.2.5 Spain

        6. 5.5.2.6 Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. 5.5.3.1 China

        2. 5.5.3.2 Japan

        3. 5.5.3.3 India

        4. 5.5.3.4 Australia

        5. 5.5.3.5 South Korea

        6. 5.5.3.6 Rest of Asia-Pacific

      4. 5.5.4 Middle East and Africa

        1. 5.5.4.1 GCC

        2. 5.5.4.2 South Africa

        3. 5.5.4.3 Rest of Middle East and Africa

      5. 5.5.5 South America

        1. 5.5.5.1 Brazil

        2. 5.5.5.2 Argentina

        3. 5.5.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 COMPANY PROFILES

      1. 6.1.1 Church & Dwight Co. Inc.

      2. 6.1.2 Fairhaven Health LLC

      3. 6.1.3 Fertility Focus Limited

      4. 6.1.4 Geratherm Medical AG

      5. 6.1.5 HiLin Life Products Inc.

      6. 6.1.6 Prestige Brands Holdings Inc.

      7. 6.1.7 Quidel Corporation

      8. 6.1.8 Swiss Precision Diagnostics GmbH

      9. 6.1.9 Advacare Pharma

      10. 6.1.10 Babystart

      11. 6.1.11 Biozhena

      12. 6.1.12 Alere Inc.

      13. 6.1.13 Procter & Gamble Company

      14. 6.1.14 Uebe Medical GmbH

      15. 6.1.15 Samplytics Technologies Private Limited.

      16. 6.1.16 Tempdrop LLC

      17. 6.1.17 Valley Electronics

      18. 6.1.18 PREGMATE

      19. 6.1.19 Ava Science Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Fertility Testing Devices Market market is studied from 2018 - 2026.

The Global Fertility Testing Devices Market is growing at a CAGR of 6.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Church & Dwight Co., Inc., Geratherm Medical AG, Fertility Focus Limited, Fairhaven Health, LLC, Quidel Corporation are the major companies operating in Global Fertility Testing Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!